Oliver A Hampton

Oliver A Hampton

UNVERIFIED PROFILE

Are you Oliver A Hampton?   Register this Author

Register author
Oliver A Hampton

Oliver A Hampton

Publications by authors named "Oliver A Hampton"

Are you Oliver A Hampton?   Register this Author

21Publications

1235Reads

18Profile Views

Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma.

J Pediatr Hematol Oncol 2017 11;39(8):e486-e488

*Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine/Texas Children's Hospital †Department of Pathology and Immunology ‡Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000956DOI Listing
November 2017

Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.

J Hepatol 2016 08 23;65(2):325-33. Epub 2016 Apr 23.

Center for Cell and Gene Therapy, Stem Cells and Regenerative Medicine Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA; Program in Developmental Biology, Baylor College of Medicine, Houston, TX, USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA; Graduate Program Department of Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668139PMC
August 2016

ITD assembler: an algorithm for internal tandem duplication discovery from short-read sequencing data.

BMC Bioinformatics 2016 Apr 27;17:188. Epub 2016 Apr 27.

Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12859-016-1031-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847212PMC
April 2016

Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

Blood 2014 Nov 8;124(19):3007-15. Epub 2014 Sep 8.

Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX; Department of Molecular and Human Genetics, Human Genome Sequencing Center, Division of Pediatric Hematology-Oncology, Department of Pediatrics, Program in Translational Biology and Molecular Medicine, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-05-577825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224195PMC
November 2014